Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 24, 2002
Grant Date -
N/A
app pub date -
Sep 6, 2001
filing date -
Sep 6, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to the discovery that a specific pentamer peptide amide, ALGPG-NH.sub.2, which corresponds to a viral capsid sequence, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said pentamer peptide amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully